Since MDA-7/IL-24 can initiate autocrine/paracrine production of MDA-7/IL-24, the systemic administration of this purified protein may cause serious adverse effects to humans, such as nonspecific inflammation and autoimmunity, which would restrict its therapeutic application as a pure systemically administered protein. This evidence concerns the gene IL24 and Autoimmunity.